Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Woitalla

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Expert Opinion on Pharmacotherapy|June 20, 2018
A noninterventional study evaluating the effectiveness of rotigotine and levodopa combination therapy in younger versus older patients with Parkinson's diseaseDirk Woitalla, Antoine Dunac, Ali Safavi, et al.
Plos One|January 4, 2014
Knockdown of Hsc70-5/mortalin induces loss of synaptic mitochondria in a Drosophila Parkinson's disease modelJun-Yi Zhu, Natalia Vereshchagina, Vrinda Sreekumar, et al.
Proteomics|April 26, 2013
Improving the default data analysis workflow for large autoimmune biomarker discovery studies with ProtoArraysMichael Turewicz, Caroline May, Maike Ahrens, et al.
Frontiers in Neurology|July 17, 2018
Do We Need to Rethink the Epidemiology and Healthcare Utilization of Parkinson's Disease in Germany?Sebastian Heinzel, Daniela Berg, Sebastian Binder, et al.
Neuroscience Letters|October 30, 2003
Mutation analysis of the neurofilament M gene in Parkinson's diseaseRejko Krüger, Christian Fischer, Thorsten Schulte, et al.
Pharmacoeconomics|March 19, 2021
Resource Utilization of Patients with Parkinson's Disease in the Late Stages of the Disease in Germany: Data from the CLaSP StudyChristopher Kruse, Sabrina Kretschmer, Anna Lipinski, et al.
Human Molecular Genetics|September 7, 2010
Dissecting the role of the mitochondrial chaperone mortalin in Parkinson's disease: functional impact of disease-related variants on mitochondrial homeostasisLena F Burbulla, Carina Schelling, Hiroki Kato, et al.
Journal of Neurology|August 29, 2024
Pharmacotherapy of motor symptoms in early and mid-stage Parkinson's disease: guideline "Parkinson's disease" of the German Society of NeurologyMatthias Höllerhage, Jos Becktepe, Joseph Classen, et al.
Plos One|February 27, 2010
Reduced basal autophagy and impaired mitochondrial dynamics due to loss of Parkinson's disease-associated protein DJ-1Guido Krebiehl, Sabine Ruckerbauer, Lena F Burbulla, et al.
Plos One|March 4, 2014
Highly immunoreactive IgG antibodies directed against a set of twenty human proteins in the sera of patients with amyotrophic lateral sclerosis identified by protein arrayCaroline May, Eckhard Nordhoff, Swaantje Casjens, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Expert Opinion on Pharmacotherapy|June 20, 2018
A noninterventional study evaluating the effectiveness of rotigotine and levodopa combination therapy in younger versus older patients with Parkinson's diseaseDirk Woitalla, Antoine Dunac, Ali Safavi, et al.
Plos One|January 4, 2014
Knockdown of Hsc70-5/mortalin induces loss of synaptic mitochondria in a Drosophila Parkinson's disease modelJun-Yi Zhu, Natalia Vereshchagina, Vrinda Sreekumar, et al.
Proteomics|April 26, 2013
Improving the default data analysis workflow for large autoimmune biomarker discovery studies with ProtoArraysMichael Turewicz, Caroline May, Maike Ahrens, et al.
Frontiers in Neurology|July 17, 2018
Do We Need to Rethink the Epidemiology and Healthcare Utilization of Parkinson's Disease in Germany?Sebastian Heinzel, Daniela Berg, Sebastian Binder, et al.
Neuroscience Letters|October 30, 2003
Mutation analysis of the neurofilament M gene in Parkinson's diseaseRejko Krüger, Christian Fischer, Thorsten Schulte, et al.
Pharmacoeconomics|March 19, 2021
Resource Utilization of Patients with Parkinson's Disease in the Late Stages of the Disease in Germany: Data from the CLaSP StudyChristopher Kruse, Sabrina Kretschmer, Anna Lipinski, et al.
Human Molecular Genetics|September 7, 2010
Dissecting the role of the mitochondrial chaperone mortalin in Parkinson's disease: functional impact of disease-related variants on mitochondrial homeostasisLena F Burbulla, Carina Schelling, Hiroki Kato, et al.
Journal of Neurology|August 29, 2024
Pharmacotherapy of motor symptoms in early and mid-stage Parkinson's disease: guideline "Parkinson's disease" of the German Society of NeurologyMatthias Höllerhage, Jos Becktepe, Joseph Classen, et al.
Plos One|February 27, 2010
Reduced basal autophagy and impaired mitochondrial dynamics due to loss of Parkinson's disease-associated protein DJ-1Guido Krebiehl, Sabine Ruckerbauer, Lena F Burbulla, et al.
Plos One|March 4, 2014
Highly immunoreactive IgG antibodies directed against a set of twenty human proteins in the sera of patients with amyotrophic lateral sclerosis identified by protein arrayCaroline May, Eckhard Nordhoff, Swaantje Casjens, et al.
Pageof 7